Docket #: S20-306
Understanding theta oscillations' role in driving empathy in psychiatric conditions and Alzheimer's disease
Researchers in the Lee lab have discovered a totally novel approach to restore the impairment of empathy associated with many neurological disorders and mental illnesses.
Serious mental illnesses and neurological disorders affect millions of adults worldwide. While these conditions exhibit a diverse of array of symptoms, the impairment of empathy is often observed across them. Impairment of empathy, together with other social deficits, are some of the main impediments preventing patients suffering from these conditions from living a normal life. Currently, there are no therapeutic options addressing this need. The Lee lab's novel approach to restore impaired empathy promises to be an invaluable asset in addressing this critical unmet need.
Applications
- Mental Illnesses
- Depression
- Bipolar disorder
- Anxiety disorder
- Schizophrenia
- Obsessive Compulsive disorder
- Alexithymia
- Psychopathy
- Addiction
- Alzheimer's disease
- Dementia
- Epilepsy
Advantages
- Currently, there are no methods available to restore empathy in patients.
Related Links
Patents
- Published Application: WO2022072716
- Published Application: 20230364423
Similar Technologies
-
Potent MET receptor agonists and antagonists S10-337Potent MET receptor agonists and antagonists
-
Temporally Precise, Genetically Targeted Optical Control of Neural Circuitry S05-170Temporally Precise, Genetically Targeted Optical Control of Neural Circuitry
-
Genetically-Targetable Optical Inactivation of Excitable Cells S06-398AGenetically-Targetable Optical Inactivation of Excitable Cells